These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 38730285

  • 21. A high prevalence of parvovirus B19 DNA in patients with psoriasis.
    Yazici AC, Aslan G, Baz K, Ikizoglu G, Api H, Serin MS, Tezcan S, Emekdas G, Tasdelen B.
    Arch Dermatol Res; 2006 Oct; 298(5):231-5. PubMed ID: 16862431
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.
    Jain A, Jain P, Prakash S, Kumar A, Khan DN, Seth A, Gupta S, Kant R.
    J Med Virol; 2016 Nov; 88(11):1922-9. PubMed ID: 27116539
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Detection of parvovirus B19 in synovial fluids of patients with osteoarthritis.
    Aslan B, Serin MS, Aslan G, Kalaci A, Yanat AN, Tezcan S, Emekdas G.
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):381-5. PubMed ID: 18096351
    [Abstract] [Full Text] [Related]

  • 28. Acute pericarditis and transient erythroblastopenia associated with human parvovirus B19 infection.
    Ergül Y, Nişli K, Keleşoğlu F, Dindar A.
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):349-51. PubMed ID: 21200105
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
    Jain P, Jain A, Prakash S, Khan DN, Singh DD, Kumar A, Moulik NR, Chandra T.
    J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The immune response to parvovirus B19 exposure in previously seronegative and seropositive individuals.
    Doyle S, Corcoran A.
    J Infect Dis; 2006 Jul 15; 194(2):154-8. PubMed ID: 16779720
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.
    Zadsar M, Aghakhani A, Banifazl M, Kazemimanesh M, Tabatabaei Yazdi SM, Mamishi S, Bavand A, Sadat Larijani M, Ramezani A.
    J Med Virol; 2018 Aug 15; 90(8):1318-1322. PubMed ID: 29663448
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A, Addo-Yobo E, Owusu-Ofori S, Akpene H, Sarkodie F, Allain JP.
    Transfusion; 2006 Sep 15; 46(9):1593-600. PubMed ID: 16965589
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.